ADVERTISEMENT
The 69th Annual Meeting of the American Epilepsy Society 2015
The 69th Annual Meeting of the American Epilepsy Society (AES) 2015 was held at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. Attendees for this meeting included distinguished epilepsy professionals from more than 65 countries from all across the care continuum and research spectrum.
The AES is one of the oldest neurological professional organizations in the United States, promoting interdisciplinary communications, scientific investigation, and exchange of clinical information about epilepsy and covering both pediatric- and adult-onset epilepsy.
The AES Annual Meeting brings together diverse professionals who are involved in both research and clinical care for people with epilepsy—neurologists, epileptologists, neurophysiologists, neuroscientists, neurosurgeons, internists, pediatricians, pharmacists, nurses, social workers, and other professionals—from private practice, academia, industry, and government.
This gathering of experts provides an unmatched opportunity to discover the best science, newest treatments, and most advanced technology solutions. The meeting showcased the clinical, basic, and translational research that are all essential to attaining the AES’s vision to eradicate epilepsy and its consequences.
The scientific material was carefully selected by the AES Annual Meeting and Scientific Program Committees and included more than 1500 abstracts covering a wide cross-section of topics. Through symposia, lectures, scientific exhibitions, posters, and platform presentations, the AES Annual Meeting showcased new trends and cutting-edge research that will move the field of epilepsy forward for years to come.
Comparing Geriatric-Onset Versus Non–Geriatric-Onset Epilepsy
Three presentations at the AES Meeting from the same authors address issues of assessment, recovery periods, and etiology in elderly patients with epilepsy.
Promising Results for Midazolam Nasal Spray (USL261) in Older Adults
A team of investigators at the AES conference gave two presentations of their research on the midazolam (MDZ) nasal spray (USL261), which is being developed for rescue treatment of seizures.
Impact of Polypharmacy on Older Adults With Epilepsy
Research presented at the AES Meeting surveyed seizure and epilepsy medications in stroke survivors. A systematic review of FDA and EMA labels was done to identify indications and contraindications for cardiology and epilepsy disease conditions.
